Copyright
©The Author(s) 2019.
World J Clin Oncol. Mar 24, 2019; 10(3): 149-160
Published online Mar 24, 2019. doi: 10.5306/wjco.v10.i3.149
Published online Mar 24, 2019. doi: 10.5306/wjco.v10.i3.149
Table 1 Demographic and baseline patients’ characteristics
| Demographic and baseline patient characteristics (n = 8 patients, 100%) | |
| Age (years old) | |
| < 65 | 3 (37.5%) |
| ≥ 65 | 5 (62.5%) |
| Race | |
| Asian | 2 (25%) |
| White | 3 (37.5%) |
| African | 3 (37.5%) |
| American | |
| Ethnicity | |
| Hispanic | 2 (25%) |
| Non-Hispanic | 6 (75%) |
| Weight (kg) | |
| Minimum | 56.7 |
| Median | 71.95 |
| Maximum | 111.3 |
| Height (cm) | |
| Minimum | 161 |
| Median | 170 |
| Maximum | 179 |
| BMI (kg/m2) | |
| Minimum | 19.2 |
| Median | 26.68 |
| Maximum | 39.9 |
- Citation: Wu J, Contratto M, Shanbhogue KP, Manji GA, O’Neil BH, Noonan A, Tudor R, Lee R. Evaluation of a locked nucleic acid form of antisense oligo targeting HIF-1α in advanced hepatocellular carcinoma. World J Clin Oncol 2019; 10(3): 149-160
- URL: https://www.wjgnet.com/2218-4333/full/v10/i3/149.htm
- DOI: https://dx.doi.org/10.5306/wjco.v10.i3.149